Compare Alphabet Inc Class A (GOOGL) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Alphabet Inc Class ATrade

Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Alphabet Inc Class A vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Alphabet Inc Class A trades at $352.17 (market cap $4.24T), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Alphabet Inc Class A is far larger — about 167.8× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Alphabet Inc Class A for 85 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.

	GOOGL	RPRX
Market Cap	$4.24T	$25.27B
Volume	23,392,850	3,671,183
Sector	Media	Health
52-Week High	$402.62	$63.96
52-Week Low	$236.59	$35.44
Typical Hold Time	85 Days	1 Days
Enterprise Value	$4.13T	$32.50B
Dividend Yield	0.25%	1.66%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alphabet Inc Class A

Alphabet (GOOGL) trades at $353.47, up 0.85% with strong bullish momentum. The stock shows robust fundamentals with revenue growth from $350.0B in 2024 to $402.8B in 2025 and net income surging to $132.2B. Technical indicators signal bullish momentum with the current price above key support levels. Recent earnings beats and strong analyst consensus support continued upside potential.

Outlook remains positive with 87% analyst buy ratings and $431.83 price target representing 22% upside. Key risks include antitrust scrutiny and AI competition, but Alphabet's diversified revenue streams and strong cash flow position the company for sustained growth. The combination of technical strength and fundamental excellence suggests favorable risk-reward for investors.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GOOGL

16% Buy84% Sell

Avg holding period · 85 Days

RPRX

No sentiment data available yet.

Top news

Latest headlines on both assets

GOOGL

Google's YouTube acquisition 20 years ago led to a 3,143% stock gain; shares remain a 'Strong Buy' in 2026.Finbold · 16 hours agoBullish ETF XLG narrows S&P 500 to 50 mega-cap stocks, heavily tech and chip-focused.24/7 Wall Street · 1 day agoNeutral Tech giants pledge $2.4B to boost AI-driven federal scientific research under Genesis MissionNew York Post · 1 day agoBullish View details →

RPRX

Royalty Pharma to release Q3 2026 earnings on Nov 4 with live webcast and call.GlobeNewsWire · 10 hours agoNeutral View details →

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.